全球疫苗玻璃瓶市场-2022-2029

Global Glass Vaccine Vial Market - 2022-2029

出版日期: 2022年10月18日 | 出版商:

DataM Intelligence | 英文 190 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

新疾病增加

疫苗玻璃瓶用于储存和运输旨在预防疾病爆发的疫苗。在过去的几十年里，随着新的疾病被引入社会，流行病的兴起。例如，世卫组织于 2021 年 5 月宣布埃博拉病毒爆发。 2021 年 2 月 7 日，刚果民主共和国 (DRC) 卫生部 (MOH) 宣布北基伍省维也纳卫生区出现埃博拉病毒病 (EVD) 确诊病例。为了对抗这些疾病，需要对高危人群进行大规模疫苗接种，从而在预测期内推动对疫苗玻璃瓶的需求激增。同时，对于 2021-22 年流感季节，CDC 估计美国有 1,700 例流感死亡、290 万例流感病例和 28,000 例住院治疗。这些疾病的高患病率和高复发率推动了对疫苗玻璃瓶的需求，以协助疫苗的储存和运输，促进了市场的增长。

另一方面，监管机构正在管理无菌灌装/完成操作的污染风险，以确保它们对使用玻璃包装的患者尽可能安全。结果，玻璃小瓶的生产及其灌装程序变得严格遵守政府的安全协议，阻碍了市场的增长。

全球疫苗玻璃瓶市场报告将提供对大约 51 个市场数据表、43 个数字和 190 页的访问权限

A glass vaccine vial is a small glass vessel or bottle used to store medication as liquids, especially vaccines. For sterilization, glass provides greater thermal stability, increased clarity, exceptional impermeability, excellent barrier properties, chemical tolerance, enhanced regulatory approval, and lower environmental effects. A glass vaccine vial may be made either by injecting molten glass into a mold or by sectioning and finishing the tubular glass. The major factors propelling the growth of the glass vaccine vial market are growing incidences of infectious diseases spreading across the globe, such as HIV, Ebola, Hepatitis, and more. The need to protect the population from these spreading viruses creates a higher demand for vaccination served in these vials. Further, the increasing vaccine trials and development worldwide for tackling the spread of diseases drives the demand for glass vaccine vials as vaccine trials start from a limited patient base to trial on mass population. This mass trial requires a higher number of vials for vaccine transport. Moreover, the glass material used for vials is advantageous over other materials due to thermal stability, transparency, sterilization, and more, which positively impacts the inclination towards glass vaccine vials

Market Dynamics: Increasing prevalence of new disease outbreaks

Glass vaccine vial is used to store and transport vaccines made for combating the outbreaks of diseases. The previous decades have witnessed an increase in epidemics with new diseases being introduced into society. For instance: WHO declared Ebola outbreak in May 2021. On February 7, 2021 the Ministry of Health (MOH) in the Democratic Republic of the Congo (DRC) announced that a case of Ebola virus disease (EVD) had been confirmed in Biena Health Zone, North Kivu Province. To combat these diseases, large-scale vaccination of the risk-associated population is required, which surges the demand for glass vaccine vials during the forecast period. Simultaneously, for the 2021-22 flu season so far, the CDC estimated there have been 1,700 flu deaths, 2.9 million flu cases, and 28,000 hospitalizations because of the flu in the United States. The high prevalence and reoccurrence of these diseases stir the demand for glass vaccine vails to aid in the storage and transport of vaccines, driving the market growth.

On the other hand, the regulatory bodies control the contamination risk of aseptic fill/finish operations to ensure that glass packaging is as safe as possible for the patients using it. This makes the production of glass vials and their filling procedures rigid towards government safety protocols which hinder the market growth.

Market Segmentation: Molded Glass Vial segment is projected to be the dominant segment in the market during the forecast period.

Molded glass vial dominated the global market in 2021, as the molded glass vials offer higher design flexibility which provides the vial high mechanical resistance reducing the risk of breakage. Therefore, molded glass vial's increasing usage in the glass vaccine vial product types is expected to propel segmental growth shortly.

Based on application, preventive vaccines held the dominant position in the global market during the forecast period. The sudden outbreak of diseases with concentrated risk zones propels the population to take precautions against being infected by the disease, supporting the segment growth during the forecast period. Moreover, the preventive vaccine is also expected to project a considerable CAGR during the forecast period.

Geographical Penetration: Asia Pacific is the dominating region during the forecast period

Asia-Pacific was held a dominant position in the global glass vaccine vial market in 2021. In Asia-Pacific, China is expected to represent considerable growth during the forecast period. As in the Region, the presence of major market players propels the market growth. Moreover, North America is expected to represent significant growth in terms of value during the forecast period. Well established healthcare infrastructure, along with the rise in vaccine developments, is expected to propel the market growth across the region. Glass vaccine vial market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the growth of the population and increasing patient pool, especially in India and China.

Competitive Landscape:

The glass vaccine vial market is highly competitive, owing to the presence of big food brands. The key glass vaccine vial players contributing to the growth of the global market include Schott AG, Origin Ltd, DWK Life Sciences, Nippon Electric Glass, Pacific Vial Manufacturing, Corning, SGD Pharma, Nipro, Richland Glass, Stevanato Group, Four Stars Glass, among others. The major players are adopting new product type launch and expansion strategies for global growth in the glass vaccine vial market. In November 2021, Corning opened a new pharmaceutical vial manufacturing factory in Durham, North Carolina, where it said it can produce 500 million glass vials per year to improve the domestic supply chain and deliver Covid-19 vaccines and other drugs to the U.S. and abroad.

COVID-19 Impact: Positive impact on the global glass vaccine vial market

The outbreak of COVID-19 has positively impacted the growth of the Glass Vaccine Vial market globally. The escalated cases of COVID-19 across the globe, along with the high number of vaccine trials and development coupled with COVID-19 vaccination drives, have triggered tremendous demand for glass vaccine vials. Therefore, the COVID-19 pandemic boosted the market value of the glass vaccine vial market in 2021.

The global glass vaccine vial market report would provide an access to approximately 51 market data tables, 43 figures and 190 pages

Scope and Methodology

1.1. Research Methodology
1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

3.1. Market Snippet by Product Type
3.2. Market Snippet by Application
3.3. Market Snippet by Region

4. Market Dynamics

4.1. Market impacting factors
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
4.2. Impact analysis

5. Industry Analysis

5.1. Porter's five forces analysis
5.2. Supply Chain analysis
5.3. PEST Analysis
5.4. Pricing Analysis
5.5. Reimbursement Analysis
5.6. Regulatory Analysis
5.7. Unmet Needs
5.8. Patent Trends

6. COVID-19 Analysis

6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives

7. By Product Type

7.1. Introduction
- 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Product Type Segment
- 7.1.2. Market attractiveness index, By Product Type Segment
7.2. Molded Glass Vial*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
7.3. Tubular Glass Vial

8. By Application

8.1. Introduction
- 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Application Segment
- 8.1.2. Market attractiveness index, By Application Segment
8.2. Preventive Vaccine *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
8.3. Therapeutic Vaccine

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key region-specific dynamics
- 9.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
  - 9.2.5.1. U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. South America
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
  - 9.3.5.1. Brazil
  - 9.3.5.2. Argentina
  - 9.3.5.3. Rest of South America
9.4. Europe
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
  - 9.4.5.1. Germany
  - 9.4.5.2. U.K.
  - 9.4.5.3. France
  - 9.4.5.4. Spain
  - 9.4.5.5. Italy
  - 9.4.5.6. Rest of Europe
9.5. Asia Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1. Competitive scenario
10.2. Competitor strategy analysis
10.3. Market positioning/share analysis
10.4. Mergers and acquisitions analysis

11. Company Profiles

11.1. Schott AG*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Key Highlights
- 11.1.4. Financial Overview
11.2. Origin Ltd
11.3. DWK Life Sciences.
11.4. Nippon Electric Glass.
11.5. Pacific Vial Manufacturing.
11.6. SGD Pharma.
11.7. CORNING
11.8. NIPRO
11.9. RICHLAND GLASS
11.10. Stevanato Group
11.11. FOUR STARS GLASS
List not Exhaustive*